Skip to content

Neuroimaging and genetic mechanisms of anhedonia in depression

Neuroimaging and genetic mechanisms of anhedonia in depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067959
Enrollment
Unknown
Registered
2023-02-01
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

depression with anhedonia:medication
depression without anhedonia:medication
Healthy controls:None

Sponsors

Affiliated Mental Health Centre & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patient group: Age between 18 and 45 years old; female and male; right handedness; Chineses; Primary school education or above; patients with first-episode depression who were drug-naive or who were previously treated with a single antidepressant; meet the criteria of depression in DSM-5; participants are voluntary to participate the study. The depression with anhedonia group is defined as SHAPS scores more than 5; the depression without anhedonia group is defined as SHAPS scores equal or less than 4. Healthy control group: Age between 18 and 45 years old; female and male; right handedness; Chineses; Primary school education or above; never diagnosed with any mental disorders in DSM-5; participants are voluntary to participate the study.

Exclusion criteria

Exclusion criteria: Patient group:Diagnosed with brain organic diseases, neurological diseases, serious endocrine or metabolic diseases; had a craniocerebral injury with a history of coma; diagnosed with other psychiatric disorders in DSM-5; unable to complete the test effectively; fitted with fixed metal dentures, pacemakers, or metal prostheses. Healthy control group: Diagnosed with any mental disorders in DSM-5; Diagnosed with any brain organic diseases, neurological diseases, serious endocrine or metabolic diseases; had a craniocerebral injury with a history of coma; had a family history of psychiatric disorders; had taken any medication to treat psychiatric disorders; fitted with fixed metal dentures, pacemakers, or metal prostheses.

Design outcomes

Primary

MeasureTime frame
SHAPS scores;HAMD scores;

Countries

China

Contacts

Public ContactSugai Liang, Zhonglin Tan

Affiliated Mental Health Centre & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine

sgl011@163.com+86 15928421891, +86 13858152049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026